Vascular biomarkers derived from dynamic contrast-enhanced MRI predict response of vestibular schwannoma to antiangiogenic therapy in type 2 neurofibromatosis.
Li, K Djoukhadar, I Zhu, X Zhao, S Lloyd, S McCabe, M McBain, Catherine A Evans, D Jackson, A
Li, K
Djoukhadar, I
Zhu, X
Zhao, S
Lloyd, S
McCabe, M
McBain, Catherine A
Evans, D
Jackson, A
Citations
Altmetric:
Abstract
Antiangiogenic therapy of vestibular schwannoma (VS) in type 2 neurofibromatosis can produce tumor shrinkage with response rates of 40%-60%. This study examines the predictive value of parameter-derived MRI in this setting.
Description
Date
2015-08-26
Publisher
Collections
Keywords
Type
Article
Citation
Vascular biomarkers derived from dynamic contrast-enhanced MRI predict response of vestibular schwannoma to antiangiogenic therapy in type 2 neurofibromatosis. 2015: Neuro-oncology